The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
2-Amino-8-(tert-butyl)-4-(2-methyl-1H-indol-3-yl)-6-(4-oxo-3,4-dihydroquinazolin-2-yl)-4H-chromene-3-carbonitrile ID: ALA5285667
Max Phase: Preclinical
Molecular Formula: C31H27N5O2
Molecular Weight: 501.59
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: Cc1[nH]c2ccccc2c1C1C(C#N)=C(N)Oc2c1cc(-c1nc3ccccc3c(=O)[nH]1)cc2C(C)(C)C
Standard InChI: InChI=1S/C31H27N5O2/c1-16-25(18-9-5-7-11-23(18)34-16)26-20-13-17(29-35-24-12-8-6-10-19(24)30(37)36-29)14-22(31(2,3)4)27(20)38-28(33)21(26)15-32/h5-14,26,34H,33H2,1-4H3,(H,35,36,37)
Standard InChI Key: GRJJYERIHNQHKF-UHFFFAOYSA-N
Molfile:
RDKit 2D
38 43 0 0 0 0 0 0 0 0999 V2000
3.2272 -1.3555 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.5113 -0.9455 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7900 -1.3613 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1.0757 -0.9489 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.0736 -0.1182 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7895 0.2944 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5093 -0.1145 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.2240 0.2973 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.9387 0.7094 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.7849 1.1216 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.1109 1.6076 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.3647 2.3986 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.1955 2.4019 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.4552 1.6127 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.2636 1.4474 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8154 2.0615 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.5560 2.8496 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.7447 3.0238 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.3271 1.3496 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.3565 0.2914 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.3585 -0.1208 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.3575 -0.9506 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.3560 -1.3638 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.3595 -2.1940 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.0729 0.2919 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.7926 -0.1242 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-2.5056 0.2938 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.5056 1.1234 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.7905 1.5350 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.0729 1.1215 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-1.7905 2.3601 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-3.2227 1.5341 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.9387 1.1234 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.9387 0.2938 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.2227 -0.1252 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.0799 -2.6059 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.3590 -2.6089 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.3595 -3.0238 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
3 2 1 0
4 3 1 0
5 4 2 0
5 6 1 0
2 7 2 0
7 6 1 0
7 8 1 0
9 8 3 0
10 6 1 0
11 10 2 0
12 11 1 0
13 12 1 0
14 13 2 0
14 10 1 0
14 15 1 0
15 16 2 0
16 17 1 0
17 18 2 0
13 18 1 0
19 11 1 0
5 20 1 0
20 21 2 0
21 22 1 0
22 23 2 0
4 23 1 0
24 23 1 0
25 21 1 0
26 25 2 0
27 26 1 0
28 27 2 0
28 29 1 0
25 30 1 0
30 29 1 0
31 29 2 0
28 32 1 0
32 33 2 0
33 34 1 0
34 35 2 0
27 35 1 0
24 36 1 0
24 37 1 0
24 38 1 0
M END Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Topical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 501.59Molecular Weight (Monoisotopic): 501.2165AlogP: 5.90#Rotatable Bonds: 2Polar Surface Area: 120.58Molecular Species: NEUTRALHBA: 5HBD: 3#RO5 Violations: 2HBA (Lipinski): 7HBD (Lipinski): 4#RO5 Violations (Lipinski): 2CX Acidic pKa: 7.94CX Basic pKa: 4.08CX LogP: 5.53CX LogD: 5.44Aromatic Rings: 5Heavy Atoms: 38QED Weighted: 0.28Np Likeness Score: -0.78
References 1. Sardar A, Ansari A, Gupta S, Sinha S, Pandey S, Rai D, Kumar M, Bhatta RS, Trivedi R, Sashidhara KV.. (2022) Design, synthesis and biological evaluation of new quinazolinone-benzopyran-indole hybrid compounds promoting osteogenesis through BMP2 upregulation., 244 [PMID:36219902 ] [10.1016/j.ejmech.2022.114813 ]